Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 858 results for "mylan"

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts
MassDevice

Abbott Laboratories: Analysis Of Q3 Earnings Miss

Summary Despite a fall in revenues and tax-events inspired drop in EPS, signs of Mylan deal still being strong gave a moderate spin to Abbott's 3Q earnings. Shares fell, but Abbott's performance has been better than that of the S&P over the year. ... Seeking Alpha, 2 days ago
Tax fear can't stop Abbott and Mylan Pharma In Focus, 1 day ago
[x]  

36 images for mylan

MassDevice, 3 days ago
ArtNet.com, 3 days ago
Pharma Letter, 2 days ago
Pittsburgh Post-Gazette, 3 days ago
CTV News, 1 week ago
State Journal, 2 days ago
Pharma Letter, 2 days ago
Reuters UK, 1 week ago
Pharma Letter, 2 days ago
Reuters UK, 2 days ago
Reuters India

U.S. court upholds patents on Pfizer's cancer drug

Oct 23 (Reuters) - A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said. Pfizer filed the lawsuit in June 2010 after Mylan attempted ...
 Yahoo! Finance2 days ago
[x]  
Securities Technology Monitor

Mylan recalls blood pressure med, following recalls of generic by two other drugmakers

Mylan's recall of metoprolol succinate tablets is for a different cause than Wockhardt's and Dr. Reddy's Share Tools Another drugmaker is having to recall metoprolol succinate extended release tablets, a generic for AstraZeneca ($AZN) ...
 FiercePharmaManufacturing4 days ago Health Canada announces Mylan begins voluntary recall of certain lots of nitroglycerin spray  PharmaBiz1 week ago Mylan Inc. Recalls Certain Lots Of Mylan-Nitro Sublingual Spray  BioSpace1 week ago Information Update - Updated consumer information on Mylan Pharmaceuticals nitroglycerin spray recall  RCL Advisors1 week ago
[x]  

Mylan faces investor pressures over use of drugs in US executions

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 19 hours for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma6 days ago Mylan launches generic HIV-1 drug  Individual.com2 weeks ago Mylan unveils generic Combivir in the US, strengthening its growing antiretroviral franchise in the nation  Individual.com2 weeks ago Mylan raises guidance for Q3  Individual.com2 weeks ago
[x]  
Business Standard

Strides fails to get $250 mn of $1.7-bn transaction with Mylan

ides Arcolab, the Bangalore-based publicly held pharmaceutical company, said that it will be getting only $150 million of the $250 million which was supposed to flow into the company as part of an transaction with US-based generics major Mylan. Strides ...
 Business Standard4 weeks ago Strides Arcolab slumps after final settlement with Mylan  Business Standard1 month ago Strides to receive USD 150 mn for final settlement from Mylan  Myiris1 month ago Strides Arcolab: Updates on Agila transaction  Money Control1 month ago
[x]  
Business Standard

Venus Remedies surges 18% in three days on marketing tie-up with Mylan

The company has entered into a distribution-cum-outlicensing agreement with Mylan for marketing its generic broad-spectrum antibiotic 'Meropenem' in three European countries. SI Reporter | Mumbai September 10, 2014 Last Updated at 09:42 IST Venus Remedies has ...
 Business Standard1 month ago Venus Pharma inks pact with Mylan for marketing meropenem in 3 European countries  Business Standard1 month ago Venus arm in marketing tie-up with Mylan  Business Standard1 month ago Venus eyes USD 15 mn from meropenem; ties up with Mylan  Business Standard1 month ago
[x]  
Business Standard

Natco Pharma gains 5%; hits 52-week high

company announced that its marketing partner in the USA, Mylan Inc has filed ANDA and has been accepted by USFDA SI Reporter | Mumbai September 1, 2014 Last Updated at 13:25 IST Natco Pharma has gained 5% to Rs 1267 also its 52-week high on the BSE after the ...
 Business Standard1 month ago Natco Pharma hits record high  Business Standard1 month ago Natco Pharma at record high; partner Mylan files ANDA  Money Control1 month ago Natco Pharma`s partner Mylan files ANDA for Copaxone  Myiris1 month ago
[x]  

Venus Remedies up on pact with Mylan

In terms of volume, 3.14 lakh shares of the company changed hands at the BSE, while over 11 lakh shares were traded at the NSE during the day. MUMBAI: Shares of Venus Remedies surged over 8 per cent as Venus Pharma GmbH, a subsidiary of the pharma major ...
 Economic Times1 month ago Venus Remedies shares up as unit enters into pact with Mylan  Business Standard1 month ago Venus Remedies surges as unit enters into pact with Mylan  Business Standard1 month ago Venus Remedies extends recent steep rally  Business Standard1 month ago

Biocon Q2 FY15 Revenues at 773 Crore, PAT at 102 Crore [Global Data Point]

Highlights: "Biocon's partner Mylan begins multicenter phase III clinical trials for insulin glargine in the United States. "Biocon, through its subsidiary Biocon Research Limited (BRL) , buys back GE Equity International Mauritius 's 7.69% ...
 Pharmacy Choice3 days ago Biocon Q2 FY15 Revenues at Rs 773 Crore, PAT at Rs 102 Crore Branded Formulations Records Strong Growth of 17%  Web Newswire3 days ago Biocon up 3% post Mylan's phase-3 trials for Glargine  Money Control1 month ago Biocon-Mylan start global phase-3 trials for drug Glargine  Money Control1 month ago
[x]  
Business Standard

Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms

Seven India-based firms - Ranbaxy, Cipla, Mylan, Cadila, Hetero, Sequent and Strides Arcolab - will produce hepatitis C medicines for distribution in 91 developing countries BS B2B Bureau | New Delhi September 17, 2014 Last Updated at 13:18 IST In what could ...
 Business Standard1 month ago Gilead Sciences picks India to lower drug cost  Asian Age1 month ago Gilead licenses hepatitis C drugs to 7 India-based pharma cos  Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less